Patient's Whole Process Follow-up Management(HOPE-1)

Recruiting now

Conditions studied: Locally Advanced Non-Small Cell Lung Cancer, Metastatic NSCLC

In brief

Our project is going to explore whether management and follow-up of locally advanced/metastatic patients using the patient process management platform can prolong patient survival and improve patient quality of life.

Key facts

Study ID

NCT05339568

Run by

Qianfoshan Hospital

People needed

1268

Starts

2022-05-22

Expected to finish

2030-08-20

Last updated by the study team

2022-09-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Fully understand the research and voluntarily sign the informed consent form (ICF)
• Male or female subjects who are over 18 years old (inclusive) at the time of signing the informed consent form.
• The subject is diagnosed pathologically or cytologically with non-small cell lung cancer(NSCLC).
• According to the 8th edition of the American Joint Committee on Cancer [AJCC], it is classified as stage IIB, stage III, stage IV NSCLC.
• Not suitable for radical treatment or refuse surgery.
• The life expectancy is not less than 3 months.
• Be able to use a smartphone.

You may not qualify if…

• Patients with mental illness.
• Presence of any other malignant tumor.
• Patients who are expected to undergo radical surgery.
• Currently participating in clinical trials.
• Subjects who judged by the investigator to be unsuitable to participate in the trial.

Where it is running

• The First Affiliated Hospital of Shandong First Medical University — Jinan, Shandong, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.